Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
3-Year Return on Invested Incremental Capital (3-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 3-year.
Athanase Innovation AB does not have enough data to calculate 3-Year ROIIC %.
Athanase Innovation AB (OSTO:ATIN) 3-Year ROIIC % Explanation
Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.
High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
Be Aware
It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.
Athanase Innovation AB 3-Year ROIIC % Related Terms
Athanase Innovation AB 3-Year ROIIC % Historical Data
* Premium members only.
The historical data trend for Athanase Innovation AB's 3-Year ROIIC % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
OSTO:ATIN vs EVG, SMM, NHS: 3-Year ROIIC % Comparison
For the Asset Management subindustry, Athanase Innovation AB's 3-Year ROIIC %, along with its competitors' market caps and 3-Year ROIIC % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Athanase Innovation AB 3-Year ROIIC % vs Asset Management Industry
For the Asset Management industry and Financial Services sector, Athanase Innovation AB's 3-Year ROIIC % distribution charts can be found below:
* The bar in red indicates where Athanase Innovation AB's 3-Year ROIIC % falls into.
Athanase Innovation AB's 3-Year ROIIC % for the quarter that ended in Jun. 2019 is calculated as:
3-Year ROIIC %
=
3-Year Incremental Net Operating Profit After Taxes (NOPAT)**
/
3-Year Incremental Invested Capital**
=
( 16.8518508 (Jun. 2019) - (Jun. 2016) )
/
( 685.036 (Jun. 2019) - (Jun. 2016) )
=
/
=
N/A%***
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
** Annual data of NOPAT and Invested Capital was used to calculate 3-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.
Athanase Innovation AB (OSTO:ATIN) has a 3-Year ROIIC % of 0.00 as of Jun. 2019. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on Athanase Innovation AB and its competitors.
Is Athanase Innovation AB's 3-Year ROIIC % too high?
Athanase Innovation AB's current 3-Year ROIIC % is 0.00. Overall, Athanase Innovation AB has a GF Score™ of 26/100, reflecting its overall financial health beyond just this single metric.
How does Athanase Innovation AB's 3-Year ROIIC % compare to EVG and SMM?
Athanase Innovation AB's 3-Year ROIIC % of 0.00 can be compared against companies in the Asset Management industry. The industry median 3-Year ROIIC % is 1.89. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year ROIIC % for an Asset Management company?
The median 3-Year ROIIC % among Asset Management companies is 1.89, based on 657 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year ROIIC % significantly above this median, while those in the bottom quartile fall well below. However, 3-Year ROIIC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year ROIIC % mean?
A high 3-Year ROIIC % can signal that a stock is expensive relative to its fundamentals. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on Athanase Innovation AB and its competitors. For the Asset Management industry, the median 3-Year ROIIC % is 1.89 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Athanase Innovation AB's current 3-Year ROIIC % is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Athanase Innovation AB stock overvalued right now?
Athanase Innovation AB (OSTO:ATIN) has a current 3-Year ROIIC % of 0.00. The current 3-Year ROIIC % is 0.00. Athanase Innovation AB's overall GF Score™ is 26/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year ROIIC % calculated?
3-Year ROIIC % is calculated from a company's financial statements. For Athanase Innovation AB (OSTO:ATIN), the current 3-Year ROIIC % is 0.00 as of Jun. 2019. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Athanase Innovation AB is an alternative investment firm with exposure to both private and public equity. It invests in innovative companies that benefit from trends such as robotics, digitalization, and automation. The principal revenue stream is initially management fees charged on the external fund capital and investment income of the underlying assets.
26GF Score
Get the complete analysis for OSTO:ATIN
3-Year ROIIC % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OSTO:ATIN has been successfully added to your 
